- Infinity Pharmaceuticals Inc and MEI Pharma Inc Merger Agreement Call - Pre-recorded TranscriptJun 19, 2023
- Infinity Pharmaceuticals Inc and MEI Pharma Inc Merger Agreement Call TranscriptFeb 23, 2023
- Q3 2022 Infinity Pharmaceuticals Inc Earnings Call TranscriptNov 14, 2022$0.7402 (-37.80%)Earnings
- Q2 2022 Infinity Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022$0.74 (-8.56%)Earnings
- Q1 2022 Infinity Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022$0.84 (+6.99%)Earnings
- Q4 2021 Infinity Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022$0.9953 (+0.52%)Earnings
- Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Infinity Pharmaceuticals Inc at 2021 San Antonio Breast Cancer Symposium - Conference Call TranscriptDec 10, 2021
- Q3 2021 Infinity Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021$2.63 (-0.38%)Earnings
- Infinity Pharmaceuticals Inc KOL Webinar to Discuss MARIO-3 and MARIO-275 Phase 2 Trials TranscriptJul 27, 2021
- Q1 2021 Infinity Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2021$2.66 (-5.67%)Earnings
- Q4 2020 Infinity Pharmaceuticals Inc Earnings Call TranscriptMar 16, 2021$3.1 (-3.73%)Earnings
- Infinity Pharmaceuticals Inc to Discuss Clinical Data from MARIO-275 - Conference Call TranscriptFeb 11, 2021
- Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Infinity Pharmaceuticals Inc at 2020 San Antonio Breast Cancer Symposium - Conference Call TranscriptDec 09, 2020
- Q3 2020 Infinity Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2020$1.15 (+1.77%)Earnings
- Q2 2020 Infinity Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020$0.8282 (+0.39%)Earnings
- Q1 2020 Infinity Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2020$1.01 (-9.01%)Earnings
- Q4 2019 Infinity Pharmaceuticals Inc Earnings Call TranscriptMar 03, 2020$1.1 (-6.78%)Earnings
- Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Infinity Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2019$1.02 (-3.77%)Earnings
- Q2 2019 Infinity Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2019$1.57 (-1.26%)Earnings
- Q1 2019 Infinity Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019$1.7 (-0.58%)Earnings
- Q4 2018 Infinity Pharmaceuticals Inc Earnings Call TranscriptMar 14, 2019$1.91 (+24.03%)Earnings
Infinity Pharmaceuticals Inc KOL Webinar to Discuss MARIO-3 and MARIO-275 Phase 2 Trials Transcript
Good morning, and welcome to the Infinity Pharmaceuticals KOL event on the MARIO-275 UC study update and the MARIO-3 TNBC study update. (Operator Instructions) As a reminder, today's event is being recorded, and a replay will be made available on the Infinity Pharmaceuticals website following the conclusion of today's event.
I would now like to turn the call over to your host, Jayne Kauffman, Senior Administrative Manager at Infinity. Please go ahead, Jayne.
Good morning, everyone, and welcome to today's call, where we will review data updates from MARIO-275 in second-line urothelial cancer and MARIO-3 in first-line triple-negative breast cancer. Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals; and Dr. Erika Hamilton, Director of the Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute at Tennessee Oncolgy and MARIO-3 lead study
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)